Susquehanna International Group
CTNM

Susquehanna International Group’s Contineum Therapeutics CTNM Stock Holding History

Susquehanna International Group’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$79.9K Buy
20,131
+6,874
+52% +$27.3K ﹤0.01% 5940
2025
Q1 		$92.5K Buy
+13,257
New +$92.5K ﹤0.01% 5878